Axcelis Technologies exceeded expectations in Q2, signaling a possible cyclical bottom. Stock surged 9.6% after earnings report, with large y/y declines but solid guidance. Revenue down 24.2% to $194.5 million, EPS down 35% to $1.13. Company sees potential in wider ion implant applications, despite current market challenges.

Axcelis manufactures ion implant machines for silicon wafers, with 55% of revenue from power chips. Follow-on order indicates expanding applications. Despite downturn in end markets like EVs, stock remains undervalued. Company boasts strong balance sheet and potential for growth in emerging power chip markets.

Investors may be eyeing Axcelis for future growth in EV and ion implant markets. While recovery could be slow, demand for silicon carbide-based power chips is increasing in various sectors. Company stands to benefit as one of few major ion implant machine producers, particularly in power-intensive applications.

Read more at Yahoo Finance: Why Axcelis Technologies Skyrocketed Today